154 related articles for article (PubMed ID: 11156476)
1. Oncogenic osteomalacia secondary to nasal tumor with decreased urinary excretion of cAMP.
Kawai Y; Morimoto S; Sakaguchi K; Yoshino H; Yotsui T; Hirota S; Inohara H; Nakagawa T; Hattori K; Kubo T; Yang J; Fujiwara N; Ogihara T
J Bone Miner Metab; 2001; 19(1):61-4. PubMed ID: 11156476
[No Abstract] [Full Text] [Related]
2. [Tumor-induced hypophosphatemic osteomalacia].
Ito N; Fukukmoto S
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):731-6. PubMed ID: 17506312
[No Abstract] [Full Text] [Related]
3. Oncogenic osteomalacia in a patient with a fibrocystic nodule of the breast.
Gascón A; Cobeta-Garcia JC; Iglesias E; Lázaro JM; Muniesa JA
Nephrol Dial Transplant; 1999 Jun; 14(6):1561-3. PubMed ID: 10383027
[No Abstract] [Full Text] [Related]
4. Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma.
Leaf DE; Pereira RC; Bazari H; Jüppner H
J Clin Endocrinol Metab; 2013 Mar; 98(3):887-91. PubMed ID: 23393166
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D metabolite levels in oncogenic osteomalacia.
Sweet RA; Males JL; Hamstra AJ; DeLuca HF
Ann Intern Med; 1980 Aug; 93(2):279-80. PubMed ID: 7406381
[TBL] [Abstract][Full Text] [Related]
6. Bilateral subtrochanteric fractures in tumour-induced osteomalacia caused by a nasal haemangiopericytoma.
Burnand H; Samuels A; Hagan I; Sawant N; Mutimer J
Hip Int; 2012; 22(2):227-9. PubMed ID: 22547377
[TBL] [Abstract][Full Text] [Related]
7. Extracts from tumors causing oncogenic osteomalacia inhibit phosphate uptake in opossum kidney cells.
Jonsson KB; Mannstadt M; Miyauchi A; Yang IM; Stein G; Ljunggren O ; Jüppner H
J Endocrinol; 2001 Jun; 169(3):613-20. PubMed ID: 11375132
[TBL] [Abstract][Full Text] [Related]
8. [Tumor-induced osteomalacia caused by nasal hemangiopericytoma: a case report].
Huang PY; Li YZ; Yang XM; Yu BQ; Guo L; Guo ZT; Li SS
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Aug; 54(8):615-617. PubMed ID: 31434378
[TBL] [Abstract][Full Text] [Related]
9. Hypophosphatemia related to a neuro-endocrine tumor of the pancreas: A case report.
Pickering ME; Bouvier D; Puravet A; Soubrier M; Sapin V; Oris C
Clin Biochem; 2022 Jun; 104():62-65. PubMed ID: 35337828
[TBL] [Abstract][Full Text] [Related]
10. Acquired hypophosphatemic osteomalacia associated with multiple myeloma.
Narvaez J; Domingo-Domenech E; Narvaez JA; Nolla JM; Valverde J
Joint Bone Spine; 2005 Oct; 72(5):424-6. PubMed ID: 16112595
[TBL] [Abstract][Full Text] [Related]
11. Hypophosphaturic mesenchymal tumor of the ethmoid associated with oncogenic osteomalacia.
Ungari C; Rocchi G; Rinna C; Agrillo A; Lattanzi A; Pagnoni M
J Craniofac Surg; 2004 May; 15(3):523-7. PubMed ID: 15111823
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic osteomalacia and inappropriate antidiuretic hormone secretion due to oat-cell carcinoma.
Taylor HC; Fallon MD; Velasco ME
Ann Intern Med; 1984 Dec; 101(6):786-8. PubMed ID: 6093661
[TBL] [Abstract][Full Text] [Related]
13. Tumor-induced osteomalacia: pre- and postoperative biochemical findings.
Leicht E; Biro G; Langer HJ
Horm Metab Res; 1990 Dec; 22(12):640-3. PubMed ID: 1963876
[TBL] [Abstract][Full Text] [Related]
14. Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report.
Sandhu FA; Martuza RL
J Neurooncol; 2000; 46(3):241-7. PubMed ID: 10902855
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic osteomalacia.
Weiss D; Bar RS; Weidner N
Ann Intern Med; 1985 Apr; 102(4):557. PubMed ID: 2983596
[No Abstract] [Full Text] [Related]
16. Marked hypophosphatemia with decreased serum 1,25-dihydroxyvitamin D in a patient with hepatocellular carcinoma complicating liver cirrhosis.
Mizuno Y; Masaki N; Hashimoto H; Ogata I; Aizawa C; Fujiwara K; Toda G; Mori M; Machinami R; Kurokawa K
Jpn J Med; 1991; 30(1):81-6. PubMed ID: 1713978
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic Secretion of Multiple Phosphatonins From a Deep Fibrous Histiocytoma Causing Oncogenic Osteomalacia.
Leow MKS; Dogra S; Ge X; Chuah KL; Liew H; Loke KSH; McFarlane C
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2299-e2308. PubMed ID: 33462615
[TBL] [Abstract][Full Text] [Related]
18. Bone scintigraphy in a case of oncogenous osteomalacia.
Ohta H; Nakaishi S; Oki S; Simizu M; Watanabe H; Fujikawa S; Nakade M; Watanabe H; Kohno K; Shintaku M
Clin Nucl Med; 1998 Jul; 23(7):467-9. PubMed ID: 9676956
[No Abstract] [Full Text] [Related]
19. [Tumor-induced rickets/osteomalacia].
Fukumoto S
Nihon Rinsho; 2006 Jun; Suppl 2():96-9. PubMed ID: 16817359
[No Abstract] [Full Text] [Related]
20. Octreotide therapy for tumor-induced osteomalacia.
Seufert J; Ebert K; Müller J; Eulert J; Hendrich C; Werner E; Schuüze N; Schulz G; Kenn W; Richtmann H; Palitzsch KD; Jakob F
N Engl J Med; 2001 Dec; 345(26):1883-8. PubMed ID: 11756579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
